POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE

Clinical trials for POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE explained in plain language.

Never miss a new study

Get alerted when new POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE trials appear

Sign up with your email to follow new studies for POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a cholesterol drug keep atrial fibrillation at bay after ablation?

Disease control Not yet recruiting

This trial tests whether ezetimibe, a common cholesterol-lowering medication, can reduce the return of irregular heartbeats in people with persistent atrial fibrillation who undergo catheter ablation. Half of the 120 participants will take ezetimibe daily for six months after the…

Matched conditions: POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE

Phase: PHASE4 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE

Get alerted when new POST-CATHETER ABLATION ATRIAL ARRHYTHMIA RECURRENCE trials appear

Can a cholesterol drug keep atrial fibrillation at bay after ablation?